As a result, anti-tumor effects were significantly shown in xenografted tumors with YS110 and PMX combined treatment compared to tumors with single treatment of YS110 or PMX, which was accompanied by a significantly reduced MIB-1 index. Here, MIB1 is linked to neoplasm.